Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$41,088,534
+$20,476 QoQ
Shares Held
262,178
-2.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#68
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 66%
Shared 2%
None 33%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $3,650,078,543 across 17 Drug Manufacturers - General names. NVS ranks #9 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,354,723 | $1,624,895,541 | |
| 2 | JNJ |
Johnson & Johnson
|
2,500,270 | $634,993,570 | |
| 3 | ABBV |
AbbVie Inc.
|
2,295,401 | $577,614,705 | |
| 4 | AMGN |
Amgen Inc
|
664,266 | $240,544,002 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,561,329 | $200,630,776 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
852,290 | $107,678,317 | |
| 7 | PFE |
Pfizer Inc
|
3,685,691 | $88,751,436 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,291,483 | $74,415,248 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,088,534 | 262,178 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $41,068,058 | 268,858 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $36,848,376 | 267,269 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $32,605,916 | 254,257 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $26,992,489 | 223,060 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $27,393,978 | 245,730 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $24,185,426 | 248,540 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $27,906,956 | 242,627 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $23,046,140 | 216,477 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $25,544,070 | 264,076 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $26,912,845 | 266,543 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $23,946,368 | 235,091 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $21,003,910 | 208,145 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $18,824,856 | 204,618 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $21,036,061 | 231,879 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,543,904 | 191,342 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $21,833,760 | 258,296 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $20,784,640 | 236,862 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $21,637,627 | 247,372 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $24,886,061 | 304,305 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $29,527,178 | 323,621 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $26,001,049 | 304,177 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $27,910,768 | 295,571 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $25,047,523 | 288,035 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $27,559,087 | 315,538 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $26,469,994 | 321,043 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||